Cargando…

Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study

Second primary cancer is prevalent in patients with gastrointestinal (GI) cancer, for which lung cancer is the most common and associated with high lethality. Image screening for lung cancer was proved to be effective in early diagnosis and lower mortality. However, trials of screen for lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hung-Yu, Lu, Min-Wei, Chen, Mei-Chi, Chang, Hsiu-Mei, Kuo, Chih-Hsi, Lin, Shu-Min, Wang, Chun-Hua, Chung, Fu-Tsai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738109/
https://www.ncbi.nlm.nih.gov/pubmed/33327274
http://dx.doi.org/10.1097/MD.0000000000023440
_version_ 1783623062950772736
author Huang, Hung-Yu
Lu, Min-Wei
Chen, Mei-Chi
Chang, Hsiu-Mei
Kuo, Chih-Hsi
Lin, Shu-Min
Wang, Chun-Hua
Chung, Fu-Tsai
author_facet Huang, Hung-Yu
Lu, Min-Wei
Chen, Mei-Chi
Chang, Hsiu-Mei
Kuo, Chih-Hsi
Lin, Shu-Min
Wang, Chun-Hua
Chung, Fu-Tsai
author_sort Huang, Hung-Yu
collection PubMed
description Second primary cancer is prevalent in patients with gastrointestinal (GI) cancer, for which lung cancer is the most common and associated with high lethality. Image screening for lung cancer was proved to be effective in early diagnosis and lower mortality. However, trials of screen for lung cancer generally excluded patients with a previous diagnosis of malignancy. The study aimed to investigate the outcome of second primary lung cancer and the factor that improve survival in patients with hepato-GI cancer. A total of 276 patients with secondary lung cancer were found among 3723 newly-diagnosed lung cancer patients diagnosed in Chang Gung Memorial Hospital, between 2010 and 2014. Patients’ clinical characteristics, stages and survival were recorded and analyzed. The patients were separated into 2 groups: Group I was defined as lung cancer detected in original primary cancer clinic and group II patients defined as lung cancer detected in other medical places. Sixty-nine cases with primary GI-hepatic and secondary lung cancer were diagnosed (42 (60.8%) in Group I and 27 (39.1%) in Group II). Although both groups had comparable primary cancer stages and treatment, more patients in Group I than Group II were diagnosed as early stage lung cancer (stage I-II: 40.5% vs 11.1%; P = .023). Group II had larger lung tumor sizes than Group I (4.7 vs 3.5 cm; P = .025). Group I showed better 5-year overall survival than Group II (P = .014, median survival: 27 vs 10 months). Among Group II, only 37% had received image follow up in clinic compared with 67% of Group I cases (P = .025). Patients with chest image follow up in clinics also had better 5-year overall survival (P = .043). GI-hepatic cancer was the most common primary malignancy in the lung cancer cohort. Patients had better survival outcome when secondary lung cancer was diagnosed in original primary cancer clinic. Chest image screening strategy may contribute better survival in secondary lung cancer due to detection at an earlier stage.
format Online
Article
Text
id pubmed-7738109
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77381092020-12-16 Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study Huang, Hung-Yu Lu, Min-Wei Chen, Mei-Chi Chang, Hsiu-Mei Kuo, Chih-Hsi Lin, Shu-Min Wang, Chun-Hua Chung, Fu-Tsai Medicine (Baltimore) 6700 Second primary cancer is prevalent in patients with gastrointestinal (GI) cancer, for which lung cancer is the most common and associated with high lethality. Image screening for lung cancer was proved to be effective in early diagnosis and lower mortality. However, trials of screen for lung cancer generally excluded patients with a previous diagnosis of malignancy. The study aimed to investigate the outcome of second primary lung cancer and the factor that improve survival in patients with hepato-GI cancer. A total of 276 patients with secondary lung cancer were found among 3723 newly-diagnosed lung cancer patients diagnosed in Chang Gung Memorial Hospital, between 2010 and 2014. Patients’ clinical characteristics, stages and survival were recorded and analyzed. The patients were separated into 2 groups: Group I was defined as lung cancer detected in original primary cancer clinic and group II patients defined as lung cancer detected in other medical places. Sixty-nine cases with primary GI-hepatic and secondary lung cancer were diagnosed (42 (60.8%) in Group I and 27 (39.1%) in Group II). Although both groups had comparable primary cancer stages and treatment, more patients in Group I than Group II were diagnosed as early stage lung cancer (stage I-II: 40.5% vs 11.1%; P = .023). Group II had larger lung tumor sizes than Group I (4.7 vs 3.5 cm; P = .025). Group I showed better 5-year overall survival than Group II (P = .014, median survival: 27 vs 10 months). Among Group II, only 37% had received image follow up in clinic compared with 67% of Group I cases (P = .025). Patients with chest image follow up in clinics also had better 5-year overall survival (P = .043). GI-hepatic cancer was the most common primary malignancy in the lung cancer cohort. Patients had better survival outcome when secondary lung cancer was diagnosed in original primary cancer clinic. Chest image screening strategy may contribute better survival in secondary lung cancer due to detection at an earlier stage. Lippincott Williams & Wilkins 2020-12-11 /pmc/articles/PMC7738109/ /pubmed/33327274 http://dx.doi.org/10.1097/MD.0000000000023440 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 6700
Huang, Hung-Yu
Lu, Min-Wei
Chen, Mei-Chi
Chang, Hsiu-Mei
Kuo, Chih-Hsi
Lin, Shu-Min
Wang, Chun-Hua
Chung, Fu-Tsai
Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study
title Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study
title_full Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study
title_fullStr Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study
title_full_unstemmed Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study
title_short Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study
title_sort clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: a strobe-compliant retrospective study
topic 6700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738109/
https://www.ncbi.nlm.nih.gov/pubmed/33327274
http://dx.doi.org/10.1097/MD.0000000000023440
work_keys_str_mv AT huanghungyu clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy
AT luminwei clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy
AT chenmeichi clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy
AT changhsiumei clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy
AT kuochihhsi clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy
AT linshumin clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy
AT wangchunhua clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy
AT chungfutsai clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy